A new molecular atlas of tau enables precision diagnostics and drug targeting across neurodegenerative diseases

Tau protein aggregation is a shared feature in over 20 neurodegenerative diseases (collectively referred to as “tauopathies”). New research led by Boston Children’s Hospital challenges the current “one-size-fits-all” approach to diagnosing and…

Continue Reading

News Source: medicalxpress.com